Catalyst Wire Dossier Catalyst Wire Dossier

Empagliflozin 25 mg + Metformin 1000 mg (free combination)

empagliflozin/metformin · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Empagliflozin 25 mg + Metformin 1000 mg (free combination), covering 2016-11-30 to 2016-11-30. Get the full timeline:

Most recent: Clinical Trial Update: Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions [Phase 1]

See pricing